Abstract:Background Ankylosing spondylitis (AS) is a common chronic inflammatory autoimmune disease that primarily affects the sacroiliac joints, spine and peripheral joints, and attachments of ligaments. Regulatory B cells (Bregs) are unique subpopulations of B cells with immune-regulating properties. Interestingly, different subsets of Breg cells have distinct markers and phenotypes and participate in self-immune regulation in different ways. However, the level of Breg cells in AS remains debated. Objectives This study aims to clarify the proportions of Breg cells with unique, controversial cellular markers in AS patients. Methods We explored the proportion of Breg cells in AS patients by searching literature through January 10, 2023, from 11 Databases. Random effects model was used to pool data. Heterogeneity and risk of bias were examined with the I-squared index (I2) statistic. Inconsistency was evaluated using the I2 and Egger tests to evaluate potential publication bias (STATA v.12.0). Results A total of 7 case-control studies involving 278 AS patients and 237 healthy controls (HCs) were included in this study(Table 1). No significant difference in the proportions of Breg cells was evident between AS patients and HCs[SMD=-0.324, 95%CI(-0.971, 0.323), P=0.327]. Because of a significant statistical heterogeneity observed [p<0.1, I2=89.2%], we conducted sub-analyses based on individual definitions of Breg cells. We found that the proportions of CD19+CD24hiCD38hi Breg cells have no significant difference between AS and HCs [SMD=-0.546, 95%CI (-1.126, 0.034), P=0.065](Figure 1). The level of CD19+CD24hiCD27+ Breg cells was increased in AS compared to that of HCs[SMD=0.965, 95%CI (0.339, 1.590), P=0.003] with no publication bias based on the Egger tests (t=1.35, p=0.236). Conclusion The levels of CD19+CD24hiCD27+ Breg cells were significantly increased in AS patients, suggesting that the abnormalities of Breg cell numbers and function are the critical causes in the development of AS. Acknowledgements This work was supported by the National Natural Science Foundation of China (No. 82001740). Disclosure of Interests None Declared.

Assay of Peripheral Regulatory Vδ1 T Cells in Ankylosing Spondylitis and Its Significance.

CD96 Downregulation Promotes the Immune Response of CD4 T Cells and Associates with Ankylosing Spondylitis.

Peripheral B-cell activation and exhaustion markers in patients with ankylosing spondylitis

The immune dysfunction in ankylosing spondylitis patients.

The Role of CD4+CD25high Regulatory T Cells in the Pathogenesis of Ankylosing Spondylitis

Frequency of CD4~+CD25~+CD127~(low/-)T Cells in the Peripheral Blood of Ankylosing Spondylitis Patients

Expressions of CXCR4/SDF-1 Reaction Axis and VEGF in Peripheral Blood Mononuclear Cells in Patients with Ankylosing Spondylitis and Their Correlation Analysis

Decreased Programmed Death-1 Expression on the T Cells of Patients with Ankylosing Spondylitis.

Higher frequency of peripheral blood interleukin 21 positive follicular helper T cells in patients with ankylosing spondylitis.

Vesicular traffic-mediated cell-to-cell signaling at the immune synapse in Ankylosing Spondylitis

Changes and Clinical Significance of CD8+CD122+ T Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis

Elevated Serum Level of IL-27 and VEGF in Patients with Ankylosing Spondylitis and Associate with Disease Activity

Defective Function of CD24(+)CD38(+) Regulatory B Cells in Ankylosing Spondylitis.

Alterations in peripheral T-cell and B-cell subsets in the ankylosing spondylitis patients with gut inflammation

Higher Frequency of Peripheral Blood Follicular Regulatory T Cells in Patients with New Onset Ankylosing Spondylitis

Levels of Circulating Th17 Cells and Regulatory T Cells in Ankylosing Spondylitis Patients with an Inadequate Response to Anti−TNF-α Therapy

Functional Defects in CD4 + CD25 High FoxP3 + Regulatory Cells in Ankylosing Spondylitis

The Expression and Significance of CD28, Ctla-4, CD80 and CD86 in Ankylosing Spondylitis Were Also Stimulated

Single‐cell RNA‐seq reveals altered NK cell subsets and reduced levels of cytotoxic molecules in patients with ankylosing spondylitis

AB1049 THE STATUS OF BREG CELLS IN PATIENTS WITH ANKYLOSING SPONDYLITIS

Increased Frequencies Of Th22 Cells As Well As Th17 Cells In The Peripheral Blood Of Patients With Ankylosing Spondylitis And Rheumatoid Arthritis